Inventor

YERXA BENJAMIN R

US51 patents

⚠️ This page may combine multiple inventors who share the name “YERXA BENJAMIN R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

YERXA BENJAMIN R

INSPIRE PHARMACEUTICALS INC

Method of treating dry eye disease with nicotinic acetylcholine receptor agonists

Method of treating dry eye disease with uridine triphosphates and related compounds

Dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency

Pharmaceutical formulation comprising P1-(2&#39;-deoxycytidine 5&#39;-)P4-(uridine 5&#39;-) tetraphosphate

Certain dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency

Therapeutic uses of di(uridine 5′)-tetraphosphate and salts thereof

Di-(uridine 5′)-tetraphosphate and salts thereof

Method for treating vaginal dryness with nicotinic acetylcholine receptor agonists

Therapeutic dinucleotide and derivatives

Method for large-scale production of di(uridine 5′-tetraphosphate) and salts thereof

P1-(2′-deoxycytidine 5′-)P4-(uridine 5′-)tetraphosphate, tetra-(alkali metal) salt, for treating cystic fibrosis

Pharmaceutical formulation comprising dinucleoside polyphosphates and salts thereof

Certain dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency

Compositions and methods for the treatment of glaucoma or ocular hypertension

Method of treating dry eye disease with purinergic receptor agonists

Method of treating dry eye disease with purinergic receptor agonists

Use of certain dinucleotides to stimulate removal of fluid in retinal detachment and retinal edema

Dinucleoside polyphosphate compositions and their therapuetic use as purinergic receptor agonists

Method of treating gastrointestinal tract disease with purinergic receptor agonists

Method of promoting mucosal hydration with certain uridine, adenine and cytidine diphosphates and analogs thereof

Method of promoting mucosal hydration with certain uridine, adenine and cytidine diphosphates and analogs thereof

Method of treating ciliary dyskinesia with uridine triphosphates and related compounds

Joint lubrication with P2Y purinergic receptor agonists

Method for reducing intraocular pressure using indole derivatives

Method for reducing intraocular pressure

Method of treating edematous retinal disorders

Dinucleoside polyphosphate compositions and their therapeutic use

Method of promoting cervical and vaginal secretions

Compositions for treating epithelial and retinal tissue diseases

Method for treating pain

Method of enhancing drainage of lacrimal system with purinergic receptor agonists

Method of treating dry eye disease with non-drying antihistamines

Method of treating ciliary dyskinesia with dinucleoside polyphosphate compounds or UTP analogues

Method of treating dry eye disease with purinergic receptor agonists

Method of enhancing drainage of lacrimal system with purinergic receptor agonists

Method of treating dry eye disease with purinergic receptor agonists

Di(uridine 5′)-tetraphosphate and salts thereof

Method for large-scale production of di(uridine 5&#39;)-tetraphosphate and salts thereof

Di(uridine 5′-)tetraphosphate and salts thereof

Method for treating or preventing inflammatory diseases

Di(uridine 5′-)tetraphosphate and salts thereof

P1-(2′-deoxycytidine 5′-)P4-(uridine 5′-)tetraphosphate, tetra-(alkali metal) salt, for treating sinusitis

Di(uridine 5′-)tetraphosphate and salts thereof

Method for large-scale production of di(uridine 5′)-tetraphosphate and salts thereof

Degradation-resistant mononucleoside phosphate compounds

Method of promoting cervical and vaginal secretions

UNIV NORTH CAROLINA

Composition and method for inhibiting platelet aggregation

Composition and method for inhibiting platelet aggregation

Composition and method for inhibiting platelet aggregation

INSPIRE PHARMACEUTICAL INC

Degradation-resistant mononucleoside phosphate compounds

Pharmaceutical formulation comprising P1-(2'-deoxycytidine 5'-)P4-(uridine 5'-) tetraphosphate

Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof